Abstract:Background/Aims: Autophagy is a lysosomal degradation pathway that is essential for cellular survival, differentiation, and homeostasis. Sirtuin 1 (SIRT1), a NAD(+) -dependent deacetylase, plays a pivotal role in modulation of autophagy. Recent studies found that autophagy was involved in the regulation of inflammatory response. In this study, we aimed to determine the effect of SIRT1 on autophagy and inflammation, and whether autophagy can regulate the inflammatory response in vascular adventitial fibroblasts (VAFs). Methods: Cell autophagy was evaluated by fluorescence microscope and transmission electron microscopy. The expression of protein and mRNA were determined by Western blot analysis and real time-PCR. The production of cytokine was detected by ELISA. Results: TNF-alpha induced autophagy and increased SIRT1 expression in VAFs. SIRT1 activator resveratrol enhanced TNF-alpha-induced VAF autophagy. In contrast, SIRT1 knockdown attenuated VAF autophagy. Both the Akt inhibitor MK2206 and mTOR inhibitor rapamycin further increased TNF-alpha-induced VAF autophagy. Furthermore. SIRT1 knockdown increased Akt phosphorylation and inhibited the autophagy in VAFs. However, MK2206 attenuated the effect of SIRT1 knockdown on VAF autophagy. In addition, ingenuity pathway analysis showed that there is a relationship between cell autophagy and inflammation. We found that SIRT1 knockdown increased the expression of NLRP3 and interleukin (IL)-6 and promoted the production of IL-1 beta in VAFs. Further study showed that autophagy activation decreased the expression of NLRP3 and IL-6 and inhibited the production of IL-1 beta, whereas autophagy inhibition increased the inflammatory response of VAFs. More importantly, our study showed that autophagy was involved in the degradation of NLRP3 through the autophagy-lysosome pathway. Conclusion: SIRT1 not only regulates VAF autophagy through the Akt/mTOR signaling pathway but also suppresses the inflammatory (C) 2017 The Author(s) response of VAFs through autophagy. Published by S. Karger AG, Basel

Selective autophagy of the adaptor TRIF regulates innate inflammatory signaling

Autophagy and proinflammatory cytokines: Interactions and clinical implications.

The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation

Regulation of interferon signaling in response to gut microbes by autophagy

Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and limits sepsis and rheumatoid arthritis

Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production

TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3/4-mediated innate immune responses.

The Crohn Disease-associated ATG16L1 T300A polymorphism regulates inflammatory responses by modulating TLR- and NLR-mediated signaling

Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse

Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits

Basal autophagy prevents autoactivation or enhancement of inflammatory signals by targeting monomeric MyD88

Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins

Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease

Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease

Selective autophagy of the immunoproteasomes suppresses innate inflammation

Inflammatory Bowel Disease: Dysfunction of Autophagy?

Proinflammatory TLR Signalling is Regulated by a TRAF2-dependent Proteolysis Mechanism in Macrophages.

ATG16L2 inhibits NLRP3 inflammasome activation through promoting ATG5-12-16L1 complex assembly and autophagy

SIRT1 Regulates the Inflammatory Response of Vascular Adventitial Fibroblasts through Autophagy and Related Signaling Pathway.

Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression

Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors